Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

New Quad HIV pill on track for FDA approval

May 14, 2012 Research and Development, Sales and Marketing BMS, Compera, FDA, Gilead, HIV, The Quad

Gilead Sciences’ four-in-one HIV pill has been given the thumbs up by an FDA advisory group.  The US regulator is …
News
FDA picture

Obesity drugs vie for approval as FDA panel backs lorcaserin

May 14, 2012 Research and Development, Sales and Marketing Arena, Eisai, FDA, Qnexa, lorcaserin, obesity

An FDA panel has recommended Arena’s obesity drug lorcaserin, setting up a showdown with Vivus’ Qnexa. Qnexa was recommended by an FDA panel …
News

Gamification and online communities – what can pharma do?

May 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, Facebook, Gamification, Syrum, digital marketing

Gamification is the new buzzword in digital marketing and has the potential to engage consumers more than traditional strategies. This new …
Feature
neil_weir_abpi-12

ABPI appoints new Innovation Board Chair

May 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Neil Weir, Whitehead

The senior vice president of discovery at UCB, Neil Weir, has been appointed as the next Chair of the ABPI …
Appointment
dr_jeremy_levin_web_only

Teva appoints new president and chief executive

May 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Jeremy Levin, Teva

Ex-BMS head Dr Jeremy Levin has been appointed president and chief executive of Teva.  Prior to joining Teva, Levin, who …
Appointment

Novo Nordisk appoints ex-Pfizer head

May 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Pfizer, Robert Clark, regulatory affairs

Robert Clark will be joining Novo Nordisk as vice president, regulatory affairs. Clark will lead Novo Nordisk’s US regulatory team, …
Appointment

Teva appoints new president of R&D

May 9, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Michael Hayden, R&D, Teva

Teva has appointed Dr Michael Hayden as its new president of global R&D and chief scientific officer at the firm’s …
Appointment

GSK raises bid for Human Genome Services

May 9, 2012 Research and Development, Sales and Marketing GSK, Human Genome Services, bid, takeover

The latest round in GlaxoSmithKline’s attempt to take over Human Genome Services has begun with GSK appealing directly to the …
News

Celgene appoints Thomas Moriarty as general counsel

May 9, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Celgene, Moriarty

Celgene has appointed Thomas Moriarty as its new general counsel and corporate secretary. In this position, he will be responsible …
Appointment

Pfizer releases new data for Pristiq

May 9, 2012 Research and Development, Sales and Marketing Effexor, MDD, Pfizer, Pristiq, antidepressant

Pfizer has released positive data for its established antidepressant Pristiq, as it hopes to extend the use of the drug.  …
News

The joy of segmentation

May 8, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, Michael Craig, marketing, segmentation

We are all different. Different heights, shapes, hair colour and we are not just different physically – what about our …
Feature

Former Novartis man becomes GSK’s new medical director

May 8, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, James Shannon, Novartis

James Shannon has been named GSK’s chief medical officer, and will report to R&D chairman Moncef Slaoui.  He will be …
Appointment
Roche image

Roche abandons Phase III cholesterol drug

May 8, 2012 Medical Communications, Research and Development, Sales and Marketing CETP inhibitor, Roche, cardiovascular, dalcetrapib, phase III failure

Roche has abandoned its Phase III cholesterol treatment dalcetrapib after disappointing results.The manufacturer is ceasing work on the drug, once …
News
GSK picture

GSK signs deal with academics

May 4, 2012 Research and Development, Sales and Marketing Cancer, GSK, PROTAC, Yale, academia

GlaxoSmithKline has forged another link with academia, signing a deal with Yale University to design a potential new class of …
News

GSK appoints two non-executive directors to its Board

May 3, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Jing Ulrich, Lynn Elsenhans

GlaxoSmithKline has announced that Lynn Elsenhans and Jing Ulrich will join the Board of the Company with effect from 1 …
Appointment
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026